Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration

Nephrology Dialysis Transplantation

Volumn 14, Issue 6, 1999, Pages 1541-1549

  Honda, Kazuho ^a   Nitta, Kosaku ^a   Horita, Shigeru ^a   Yumura, Wako ^a   Nihei, Hiroshi ^a   Nagai, Ryoji ^b   Ikeda, Kazuyoshi ^b   Horiuchi, Seikoh ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end product; Continuous ambulatory peritoneal dialysis; Peritoneal fibrosis; Ultra filtration failure; Vascular changes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BIOPSY; BODY WEIGHT; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PERITONEUM; PRIORITY JOURNAL; SCLEROSIS; ULTRAFILTRATION; VASCULARIZATION;

ADULT; AGED; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; ULTRAFILTRATION;

EID: 0032972996     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.6.1541     Document Type: Article

References (25)

1. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biological basis of diabetic complications. N Engl J Med 1988; 318: 1315-1321
2. Baynes JW, Monnier VM. The Maillard reaction in aging, diabetes and nutrition. Prog Clin Biol Res 1989; 304: 1-410
3. Makita Z, Radoff S, Rayfield EJ et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325: 836-842
4. Dyer DG, Dunn JA, Thorpe SR et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993; 91: 2463-2469
5. Nakamura Y, Horii Y, Nishino T et al. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol 1993; 143: 1649-1665
6. Nishino T, Horii Y, Shiiki H et al. Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy. Hum Pathol 1995; 26: 308-313
7. Miyata T, Oda O, Inagi R et al. Beta 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 92: 1243-1252
8. Papanastasiou P, Grass L, Rodela H et al. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int 1994; 46: 216-222
9. Yamada K, Miyahara Y, Hamaguchi K et al. Immunohistochemical study of human advanced glycation end-products (AGE) in chronic renal failure. Clin Nephrol 1994; 42: 354-361
10. Miyata T, Ueda Y, Shinzato T et al. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 1996; 7: 1198-1206
11. Miyata T. New aspects in the pathogenesis of dialysis-related amyloidosis: Pathophysiology of advanced glycation end products in renal failure. Jpn J Nephrol 1996; 38: 191-197
12. Nakayama M, Kawaguchi Y, Yamada K et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997; 51: 182-186
13. Honda K, Nitta K., Horita S, Yumura W, Nihei H. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 1996; 72: 171-176
14. Twardowski ZJ, Nolph KD, Khanna R et al. Peritoneal equibration test. Perit Dial Bull 1987; 7: 138-147
15. Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J Biol Chem 1991; 266: 7329-7332
16. ε-(Carboxymethyl) lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996; 35: 8075-8083
17. Schneble F, Bonzel KE, Waldherr R et al. Peritoneal morphology in children treated by continuous ambulatory peritoneal dialysis. Pediatr Nephrol 1992; 6: 542-546
18. Gotloib L, Bar-Sella P, Shostak A. Reduplicated basal lamina of small venules and mesothelium of human parietal peritoneum: Ultrastructural changes of reduplicated peritoneal basal membrane. Perit Dial Bull 1985; 5: 212-215
19. Di Paolo N, Sacchi G. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CARD): an in vivo model for the study of diabetic microangiopathy. Perit Dial Int 1989; 9: 41-45
20. Lamb EJ, Cattell WR, Dawnay ABSt.J. In vitro formation of advanced glycation end products in peritoneal dialysis fluid. Kidney Int 1995; 47: 1768-1774
21. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectine/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 1988; 240: 1546-1548
22. Kristein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990; 87: 9010-9014
23. Tsilibary EC, Charonis AS, Reger LA, Wohlheuter RM, Furcht LT. The effect of glycosylation on the binding of the main noncollagenous NCl domain to type IV collagen. J Biol Chem 1988; 263: 4302-4308
24. Charonis AS, Reger LA, Dege JE et al. Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes 1990; 39: 807-814
25. Hogan M, Cerami A, Bucala R. Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide; Role in the vascular and renal complications of diabetes mellitus. J Clin Invest 1992; 90: 1110-1115